Valium without dependence? Individual GABA A receptor subtype contribution toward benzodiazepine addiction, tolerance, and therapeutic effects.

Autor: Cheng T; Pitzer College, Claremont, CA, USA., Wallace DM; Portland State University, Portland, OR, USA., Ponteri B; Pitzer College, Claremont, CA, USA., Tuli M; University of British Columbia, Vancouver, BC, Canada.
Jazyk: angličtina
Zdroj: Neuropsychiatric disease and treatment [Neuropsychiatr Dis Treat] 2018 May 23; Vol. 14, pp. 1351-1361. Date of Electronic Publication: 2018 May 23 (Print Publication: 2018).
DOI: 10.2147/NDT.S164307
Abstrakt: Benzodiazepines are one of the most prescribed medications as first-line treatment of anxiety, insomnia, and epilepsy around the world. Over the past two decades, advances in the neuropharmacological understanding of gamma aminobutyric acid (GABA) A receptors revealed distinct contributions from each subtype and produced effects. Recent findings have highlighted the importance of α 1 containing GABA A receptors in the mechanisms of addiction and tolerance in benzodiazepine treatments. This has shown promise in the development of tranquilizers with minimal side effects such as cognitive impairment, dependence, and tolerance. A valium-like drug without its side effects, as repeatedly demonstrated in animals, is achievable.
Competing Interests: Disclosure The authors report no conflicts of interest in this work.
Databáze: MEDLINE
Externí odkaz: